SIMULECT (basiliximab): Do not use WFI ampoules co-packed with vials of sterile freeze-dried powder of Simulect 10mg and 20mg

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Simulect
Active substance
basiliximab
Therapeutic area (MeSH)
  • Graft Rejection
  • Kidney Transplantation
Procedure number
EMEA/H/C/000207
DHPC type
Quality defect
Human ATC code
L04AC02
Dissemination date
21/04/2023

How useful was this page?

Add your rating